ProQR Therapeutics (PRQR) Short-term Investments (2020 - 2023)

ProQR Therapeutics' Short-term Investments history runs 4 years deep, the most recent figure standing at $277590.6 for Q3 2023.

• In Q3 2023, Short-term Investments rose 91.19% year-over-year to $277590.6; the TTM figure through Sep 2023 stood at $277590.6 (up 91.19% YoY), while the FY2022 annual figure was $1.3 million, down 72.74% from the prior year.
• Short-term Investments came in at $277590.6 for Q3 2023 at ProQR Therapeutics, down from $405079.9 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $4.6 million in Q4 2021 to a low of $1934.8 in Q1 2021.
• A 4-year average of $1.1 million and a median of $636491.7 in 2023 frame the typical range for Short-term Investments.
• On a YoY basis, Short-term Investments climbed as much as 16084.19% in 2022 and fell as far as 94.56% in 2022.
• ProQR Therapeutics' Short-term Investments stood at $1.0 million in 2020, then soared by 356.87% to $4.6 million in 2021, then tumbled by 71.8% to $1.3 million in 2022, then sank by 78.46% to $277590.6 in 2023.
• According to Business Quant data, Short-term Investments over the past three periods registered $277590.6, $405079.9, and $636491.7 for Q3 2023, Q2 2023, and Q1 2023 respectively.

Peer Comparison